View
51
Download
3
Category
Preview:
Citation preview
A Bold Plan for Global ExpansionAn excerpt from On fast-forward: Accelerating the pace of global expansion for South Korea’s healthcare companies
What will it take for South Korea to reach its
aspiration of becoming a top-seven global powerhouse for
pharmaceuticals and medical devices by 2020?
2009 2014 20200
5
10
15
20
25
W1.7trn(US$1.5bn)
W3trn(US$2.7bn)
W13.5trn target(US$12.2bn)
1.8W2.4trn
(US$2.2bn)
W23trn target (US$20.8bn)
Exports (W trn)
W1.8trn (US$1.6bn)
Ambitious overseas growth targets that eclipse historical growth trends of South Korean healthcare companies signal the need for game-changing strategies.
CAGR 45.4%
CAGR 6.7%
CAGR 28.6%
CAGR 12.2%
3big questions underlie strategic manoeuvres for South Korean healthcare companies to deliver on growth.
1.
Where can South Korean healthcare companies find the right market opportunities?
The pattern of South Korean expansion into global healthcare markets reflects emerging opportunities in numerous product and market segments to drive growth.
Latin AmericaCentralised diagnostic equipment
US, EuropeBiosimilars
South-east Asia Imaging equipment, higher-quality healthcare services in private hospitals
ChinaMolecular diagnostics, premium healthcare services in private hospitals
JapanBiosimilars, regenerative medicine
2.
What similarities and connections exist between different markets for companies to devise a more unified strategy?
In South-east Asia, countries such as Indonesia, the Philippines and Vietnam have similar healthcare needs and similar levels of healthcare development.
New Korean hospitals established in the Korea Medical Belt, a trans-Asian medical export belt linking China, Russia, Mongolia, Central Asia, Middle East and South-east Asia can support greater use of pharmaceuticals and medical devices in the region.
3.
What market opportunities should companies focus on? How should companies prioritise their expansion efforts?
Visithttps://goo.gl/7B3nK9to download the full
report.
Recommended